Skip to content

SPAC Feed

Curated SPACs News

  • News
  • Opinions
  • Events
  • Videos
  • Resources
  • Contact Us
  • News
Posted on June 12, 2023

Starton Therapeutics Receives Authorization from the FDA to … – Business Wire

Starton Therapeutics Receives Authorization from the FDA to …  Business Wire
Source: Starton Therapeutics Receives Authorization from the FDA to … – Business Wire

By sf-admin

Post navigation

S-1 – Turnstone Biologics Corp. (0001764974) (Filer)
Starton Therapeutics Receives Authorization from the FDA to Proceed with STAR-LLD Lenalidomide Phase 1b Clinical Trial in Multiple Myeloma – Marketscreener.com


  • About Us
  • Contact Us
  • Subscribe
Copyright © 2026 SPAC Feed. All Rights Reserved | News Vibe by Theme Palace